Aluminum containing adjuvants include aluminum hydroxide adjuvants and aluminum phosphate adjuvants. Aluminum hydroxide is more widely used due to its own characteristics during use. Aluminum hydroxide adjuvant is used at 4.5 nm × 2.2 nm × Fibrous particles present at 10 nm, with an isoelectric point (ipe) of l1.4. This type of particle aggregates in loose l~10 lµ The form of m size exists.
Aluminum adjuvants are effective against many different vaccine antigens in current vaccines, have excellent safety characteristics, are associated with minimal reactivity, and are inexpensive. In addition, their practical advantage lies in providing the possibility of creating a single liquid vial or pre filled syringe, which is more widely accepted by the market. In recent years, oil-in-water emulsions and liposomes such as MF59 and ASO3 have also been included in some approved human vaccine adjuvants, and more selected adjuvants are in different stages of discovery and development.
The two commonly used aluminum adjuvants in currently approved vaccines are aluminum hydroxide adjuvant (AH) and aluminum phosphate adjuvant (AP). AH and AP from different sources may have different physical, chemical, and biological characteristics.
鋁佐劑(aluminum-containing adjuvants)包括:氫-氧-化鋁佐劑(aluminium hydroxide adjuvant)和磷-酸-鋁佐劑(aluminium phosphate)兩種。在使用過程中氫-氧-化鋁以其本身的特點而使用更加廣泛。氫-氧-化鋁佐劑是以4.5 nm×2.2 nm×10 nm存在的纖維狀粒子 ,等電點(ipe)l1.4 。這種粒子聚集后以松散的l~10 lµm大小的形式存在。
鋁佐劑對目前疫苗中的許多不同疫苗抗原有效,具有優良的安全特性,與最小的反應原性相關,且便宜。此外,它們的實際優勢在于提供了創建單一液體小瓶或預充注射器的形式的可能性,更大程度上,被市場所接受。近年來,MF59、ASO3等水包油乳劑和脂質體也被列入某些已獲批準的人用疫苗佐劑種,更多的選佐劑正處于不同的發現和開發階段。
目前已獲批準的疫苗中常用的兩種鋁佐劑是氫-氧-化鋁佐劑(AH)和磷-酸-鋁佐劑(AP),不同來源的AH和AP可能在物理、化學和生物特性上有所不同。
艾美捷OZ Biosciences氫-氧-化鋁佐劑#AH0050規格:
中文名稱:AlumVax Hydroxide 疫苗佐劑
英文名字:
AlumVax Hydroxide vaccine adjuvant
編號:OZB-AH0050
規格:50ML
儲存:室溫
運輸條件:室溫
OZ Biosciences氫-氧-化鋁疫苗佐劑的應用:
氫-氧-化鋁通過釋放Th2相關細胞因子(IL2,IL-4,IL-5...)和Th13相關抗體(IgG2和IgE)刺激Th1反應。它增加Ag特異性CD4 + T細胞增殖并促進NALP3炎癥小體活化和半胱天冬酶1介導的IL-1和IL-18釋放。
推薦的FOR:刺激Th2反應,抗體產生。
OZ Biosciences的VaxOZ佐劑僅用于研究用途。
引文數據庫:
NAME MOLECULE VECTOR PRODUCT REFERENCE
in vivo : intradermal protein Alumvax hydroxide Inoue S., Cancer Sci. 2023 Jan;114(1):34-47.
in vivo : intraperitoneal protein Alumvax hydroxide Rak S., Viruses. 2023 Jan 13;15(1):230.
in vivo: intramuscular injection protein Alumvax hydroxide Matyushenko V., Antiviral Res . 2020 Jun 22;104864.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,智慧城市網對此不承擔任何保證責任。
溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。